Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Leukemia, Myeloid, Acute 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myelodysplastic Syndromes 22Leukemia 21Lymphoma, Non-Hodgkin 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Recurrence 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma 5Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Hematologic Neoplasms 3Graft vs Host Disease 3Burkitt Lymphoma 3Neoplasms 2Neoplasm, Residual 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Bone Marrow Failure Disorders 2

Interventions

Cyclophosphamide 64Peripheral Blood Stem Cell Transplantation 48Etoposide 40Filgrastim 34Rituximab 33Radiotherapy 33fludarabine phosphate 30Busulfan 28Mycophenolic Acid 27Tacrolimus 24Cyclosporine 24Cytarabine 23Antilymphocyte Serum 22Whole-Body Irradiation 21Methotrexate 21Melphalan 21Carmustine 16sargramostim 15Methylprednisolone 15Vincristine 12Prednisone 12Cisplatin 12Doxorubicin 9Dexamethasone 9Cord Blood Stem Cell Transplantation 9Ifosfamide 8Granulocyte Colony-Stimulating Factor 7etoposide phosphate 6Sirolimus 6Carboplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Immunoblastic × Clofarabine × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡